Double-Blind, Randomized, Placebo-Controlled Trial of Metoclopramide for Hypersalivation Associated With Clozapine.

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 27028980)

Published in J Clin Psychopharmacol on June 01, 2016

Authors

Anatoly Kreinin1, Chanoch Miodownik, Vitaly Mirkin, Yulia Gaiduk, Yan Yankovsky, Yuly Bersudsky, Paul P Lerner, Joseph Bergman, Vladimir Lerner

Author Affiliations

1: From the *Mental Health Center Ma'ale Carmel, Bruce Rapaport Faculty of Medicine Technion, Haifa; †Be'er-Sheva Mental Health Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'er-Sheva; and ‡Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Associated clinical trials:

Metoclopramide as Treatment of Clozapine-induced Hypersalivation | NCT02222220

Articles citing this

Metoclopramide may be effective for clozapine-induced hypersalivation. Evid Based Ment Health (2016) 0.75

Articles by these authors

Rapid tryptophan depletion as a treatment for acute mania: a double-blind, pilot-controlled study. Bipolar Disord (2007) 1.99

Omega-3 eicosapentaenoic acid in bipolar depression: report of a small open-label study. J Clin Psychiatry (2005) 1.54

Curcumin as an add-on to antidepressive treatment: a randomized, double-blind, placebo-controlled, pilot clinical study. Clin Neuropharmacol (2013) 1.39

Evidence-based guideline: Treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2013) 1.07

Lenin's malady. Hum Pathol (2013) 1.07

Evidence-based guideline: treatment of tardive syndromes: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology (2014) 1.06

Knockout mice in understanding the mechanism of action of lithium. Biochem Soc Trans (2009) 1.02

IMPA1 is essential for embryonic development and lithium-like pilocarpine sensitivity. Neuropsychopharmacology (2007) 0.96

Homocysteine-reducing strategies improve symptoms in chronic schizophrenic patients with hyperhomocysteinemia. Biol Psychiatry (2006) 0.94

Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder. J Clin Psychopharmacol (2002) 0.93

Impaired heart rate variability in euthymic bipolar patients. Bipolar Disord (2003) 0.93

Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial. J Clin Psychiatry (2010) 0.92

Shared obsessive-compulsive disorder: broadening the concept of shared psychotic disorder. Aust N Z J Psychiatry (2010) 0.92

Vitamin B12 and folate serum levels in newly admitted psychiatric patients. Clin Nutr (2005) 0.91

The biology of tryptophan depletion and mood disorders. Isr J Psychiatry Relat Sci (2010) 0.90

Bexarotene as add-on to antipsychotic treatment in schizophrenia patients: a pilot open-label trial. Clin Neuropharmacol (2008) 0.89

GSK-3 parameters in lymphocytes of schizophrenic patients. Psychiatry Res (2002) 0.87

The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial. J Clin Psychiatry (2013) 0.87

Lithium-pilocarpine seizures as a model for lithium action in mania. Neurosci Biobehav Rev (2007) 0.86

Traumatic stress is linked to a deficit in associative episodic memory. J Trauma Stress (2011) 0.86

Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study. J Clin Psychiatry (2002) 0.86

Individual differences and evidence-based psychopharmacology. BMC Med (2012) 0.86

Successful use of donepezil for the treatment of psychotic symptoms in patients with Parkinson's disease. Clin Neuropharmacol (2002) 0.86

SMIT1 haploinsufficiency causes brain inositol deficiency without affecting lithium-sensitive behavior. Mol Genet Metab (2006) 0.85

Bayesian approach to bipolar guidelines. World J Biol Psychiatry (2010) 0.85

Lithium nephrotoxicity. Int J Bipolar Disord (2015) 0.85

Quetiapine: efficacy, tolerability and safety in schizophrenia. Expert Rev Neurother (2006) 0.84

Beneficial effect of donepezil in the treatment of elderly patients with tardive movement disorders. J Clin Psychiatry (2005) 0.83

Serum levels of brain-derived neurotrophic factor and cortisol to sulfate of dehydroepiandrosterone molar ratio associated with clinical response to L-theanine as augmentation of antipsychotic therapy in schizophrenia and schizoaffective disorder patients. Clin Neuropharmacol (2011) 0.83

Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect. Bipolar Disord (2009) 0.83

Associative memory impairment in acute stress disorder: characteristics and time course. Psychiatry Res (2013) 0.83

Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia. Int J Neuropsychopharmacol (2007) 0.82

The effect of sudden clozapine discontinuation on management of schizophrenic patients: A retrospective controlled study. J Clin Psychiatry (2006) 0.81

Vitamin B6 treatment for tardive dyskinesia: a randomized, double-blind, placebo-controlled, crossover study. J Clin Psychiatry (2007) 0.81

Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment. Curr Psychiatry Rep (2011) 0.81

Bipolar disorder: Mania and depression. Discov Med (2004) 0.80

Amisulpride versus moclobemide in treatment of clozapine-induced hypersalivation. World J Biol Psychiatry (2010) 0.80

Thought disorder in euthymic bipolar patients: a possible endophenotype of bipolar affective disorder? J Nerv Ment Dis (2007) 0.80

Tattoo designs among drug abusers. Isr J Psychiatry Relat Sci (2006) 0.80

Clotiapine compared with chlorpromazine in chronic schizophrenia. Schizophr Res (2005) 0.79

Efficacy of piracetam in the treatment of tardive dyskinesia in schizophrenic patients: a randomized, double-blind, placebo-controlled crossover study. J Clin Psychiatry (2007) 0.79

Controlled double-blind trial of phenytoin vs. fluoxetine in major depressive disorder. J Clin Psychiatry (2005) 0.79

Normobaric hyperoxia treatment of schizophrenia. J Clin Psychopharmacol (2012) 0.79

Quetiapine-associated depression in a patient with schizophrenia. Clin Neuropharmacol (2005) 0.79

High-dose vitamin B6 decreases homocysteine serum levels in patients with schizophrenia and schizoaffective disorders: a preliminary study. Clin Neuropharmacol (2007) 0.79

Human MIP synthase splice variants in bipolar disorder. Bipolar Disord (2007) 0.79

L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study. J Clin Psychiatry (2010) 0.78

The new lithium clinic. Neuropsychobiology (2010) 0.78

Lithium-induced tremor treated with vitamin B6: a preliminary case series. Int J Psychiatry Med (2002) 0.78

Delirium associated with lithium-quetiapine combination. Clin Neuropharmacol (2008) 0.78

Pyridoxal plasma level in schizophrenic and schizoaffective patients with and without tardive dyskinesia. Clin Neuropharmacol (2008) 0.78

Lymphocyte G-protein receptor kinase (GRK)3 mRNA levels in bipolar disorder. Int J Neuropsychopharmacol (2005) 0.78

[Vitamin B6 add-on therapy in treatment of schizophrenic patients with psychotic symptoms and movement disorders]. Harefuah (2003) 0.77

Role of GSK3beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci U S A (2008) 0.77

Ziprasidone-associated depressive state in schizophrenic patients. Clin Neuropharmacol (2007) 0.77

High serum homocysteine levels in young male schizophrenic and schizoaffective patients with tardive parkinsonism and/or tardive dyskinesia. J Clin Psychiatry (2005) 0.77

Vitamin B6 versus mianserin and placebo in acute neuroleptic-induced akathisia: a randomized, double-blind, controlled study. Clin Neuropharmacol (2006) 0.77

Lithium intoxication associated with intramuscular ziprasidone in schizoaffective patients. Clin Neuropharmacol (2005) 0.76

Inositol deficiency diet and lithium effects. Bipolar Disord (2006) 0.76

Amisulpride as add-on treatment for resistant obsessive-compulsive disorder: retrospective case series. Clin Neuropharmacol (2015) 0.76

Donepezil as add-on treatment of psychotic symptoms in patients with dementia of the Alzheimer's type. Clin Neuropharmacol (2003) 0.76

The prevalence of neuroleptic drug-induced tardive movement subsyndromes among schizophrenic and schizoaffective patients residing in the southern region of Israel. Isr J Psychiatry Relat Sci (2007) 0.76

Augmentation with amisulpride for schizophrenic patients nonresponsive to antipsychotic monotherapy. Clin Neuropharmacol (2005) 0.76

Neuropsychological correlates of homocysteine levels in euthymic bipolar patients. J Affect Disord (2007) 0.76

Creativity and affective illness. Am J Psychiatry (2002) 0.75

Bipolar disorder: Treatment. Discov Med (2004) 0.75

Monotherapy versus polypharmacy for hospitalized psychiatric patients. Am J Psychiatry (2005) 0.75

'Treatment of bipolar disorder: a systematic review of available data and clinical perspectives' by Fountoulakis & Vieta (2008). Int J Neuropsychopharmacol (2009) 0.75

Time to initial operative treatment following open fracture does not impact development of deep infection: a prospective cohort study of 736 subjects. J Orthop Trauma (2014) 0.75

Epi-inositol is ineffective in Porsolt Forced Swim Test model of depression. Neuropsychiatr Dis Treat (2005) 0.75

A rational approach to the use of atypical antipsychotics. Isr J Psychiatry Relat Sci (2003) 0.75

Victor Kandinsky, MD: psychiatrist, researcher and patient. Hist Psychiatry (2003) 0.75

Ethnic origin of alcoholics admitted to an Israeli treatment center. Am J Drug Alcohol Abuse (2006) 0.75

Efficacy of bupropion XR in treatment-resistant elderly patients: a case series study. Clin Neuropharmacol (2011) 0.75

Perverse political correctness and personality traits. Med Hypotheses (2011) 0.75

Moclobemide treatment of clozapine-induced hypersalivation: pilot open study. Clin Neuropharmacol (2009) 0.75

Successful Use of Escitalopram for the Treatment of Visual Hallucinations in Patients With Parkinson Disease. Clin Neuropharmacol (2017) 0.75

Psychologists' and social workers' self-descriptions using DSM-IV psychopathology. Psychol Rep (2008) 0.75

Pisa syndrome and laryngeal dystonia induced by novel antipsychotics. Isr J Psychiatry Relat Sci (2011) 0.75

Donepezil as Add-on Treatment for Resistant Obsessive-Compulsive Disorder: Retrospective Case Series. Clin Neuropharmacol (2016) 0.75

Vitamin B6 treatment in acute neuroleptic-induced akathisia: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry (2004) 0.75